Fundraising Fox
Oligon
2 known investors
Find your way into Oligon
Sign up to see every warm intro you have to Oligon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oligon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells. The biotechnology company applies AI-based molecular modeling to discover and optimize these RNA drug candidates.
Founders & leadership
Investors · 2
CTI Life Sciences Fund L.P.✓ confirmed by OligonMontréal
How we know: CTI Life Sciences Fund L.P.'s portfolio page · the company's own site · funding news · Not right? Tell us
Fonds de solidarité FTQreportedMontreal
How we know: funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Oligon do?
- Oligon Therapeutics develops RNA-based multi-targeting drugs using its SeekR platform, which combines RNA aptamer oligo-binders with siRNA silencers into a single self-delivering molecule for precise targeting of specific cell types, including T-cells and cancer cells. The biotechnology company applies AI-based molecular modeling to discover and optimize these RNA drug candidates.
- Who founded Oligon?
- Oligon was founded by Spyro Mousses.
- Who are Oligon's investors?
- Oligon's investors include CTI Life Sciences Fund L.P., Fonds de solidarité FTQ.